Profil
Hans Vassgård Eid is currently Chairman at Snøtind AS.
Former positions include Investment Director at Foinco Invest AS from 2002 to 2007, Director at Pharmaq AS from 2012 to 2015, Senior Vice President-Business Development at Storebrand ASA from 1998 to 2001, Chief Executive & Financial Officer at Ultimovacs ASA, and Chief Financial Officer at Zelluna ASA. Education includes an MBA from the Norwegian School of Economics & Business Administration.
Postes actifs de Hans Vassgård Eid
| Sociétés | Poste | Début |
|---|---|---|
Snøtind AS | Président | - |
Anciens postes connus de Hans Vassgård Eid
| Sociétés | Poste | Fin |
|---|---|---|
Pharmaq AS
Pharmaq AS Pharmaceuticals: MajorHealth Technology Operates as a veterinary pharmaceutical company | Directeur/Membre du Conseil | 01/01/2015 |
Foinco Invest AS
Foinco Invest AS Investment ManagersFinance Acts as an alternative investment manager | Directeur en chef des Investissements | 01/01/2007 |
| STOREBRAND ASA | Corporate Officer/Principal | 01/01/2001 |
Ultimovacs ASA
Ultimovacs ASA Pharmaceuticals: MajorHealth Technology Develops novel peptide based therapeutic cancer vaccine | Directeur Général | - |
Formation de Hans Vassgård Eid
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Storebrand ASA
Storebrand ASA Savings BanksFinance Provides savings, insurance and guaranteed pension services | Finance |
Foinco Invest AS
Foinco Invest AS Investment ManagersFinance Acts as an alternative investment manager | Finance |
Pharmaq AS
Pharmaq AS Pharmaceuticals: MajorHealth Technology Operates as a veterinary pharmaceutical company | Health Technology |
Norwegian School of Economics & Business Administration
Norwegian School of Economics & Business Administration Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ultimovacs ASA
Ultimovacs ASA Pharmaceuticals: MajorHealth Technology Develops novel peptide based therapeutic cancer vaccine | Health Technology |
Snøtind AS |
















